Neo-adjuvant Chemotherapy With Letrozole in Patients With Estrogen Receptor Positive/HER-2 Negative Breast Cancer
Status:
Recruiting
Trial end date:
2024-01-01
Target enrollment:
Participant gender:
Summary
This is an exploratory interventional study that initiates chemotherapy with letrozole in
patients with estrogen receptor positive/HER2-negative breast cancer preoperably.